Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 12, 2003. The report primarily discloses changes in director interests and a share repurchase transaction.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to specific share transactions:
- Share Repurchase Price: 1,298.55 pence per share.
- Retirement Fund ADR Average Price: $43.59.
Material Changes
The filing details two specific corporate actions:
- Director's Interest Change: The GlaxoSmithKline US Retirement Savings Plan increased its holdings of Ordinary Share ADRs from 18,812,224 to 18,860,128 on November 7, 2003. This change affects the potential interest of Director Dr. J.P. Garnier, as he is a beneficiary of the discretionary fund.
- Share Repurchase: On November 11, 2003, the company purchased 770,000 Ordinary 25 pence shares for cancellation under authority granted at the May 19, 2003 Annual General Meeting.
- Verify the total number of shares repurchased for cancellation in the current fiscal year to date.
- Confirm the total remaining treasury shares or authorized buyback limit following the November 11 transaction.
- Review the full composition of the US Retirement Savings Plan to understand the extent of Director Dr. J.P. Garnier's indirect exposure.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.